Shockwave Medical (Fremont, California), a company that specializes in the treatment of peripheral and coronary vascular disease, reported positive clinical results from DISRUPT PAD, a single-arm multi-center study evaluating the safety and utility of Lithoplasty balloon catheters for the treatment of peripheral artery disease, at the Vascular Interventional Advances (VIVA) Annual Conference in Las Vegas.